Welcome to the CIBRN Podcast channel. This year, we’ve decided to take a fresh approach to article reviews, providing timely and brief (3-5 minutes) podcasts on articles selected and reviewed by CIBRN members. The first in the series has been provided by Dr. Philip Baer.
CIBRN Podcast Episode 1: Dr. Philip Baer on “Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States.” Current Medical Research Opinion, April 2019, Teeple et al. (3:18)
We invite you to view the archived recording of the virtual review webinar which was held on September 20th, led by Dr. Gordon Searles featuring the recent article in Advances in Therapy by Numan et al: Non-medical Switching from Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies[link to full text]
We invite you to view the archived recording of the virtual review webinar which was held on June 20th, led by Dr. Philip Baer featuring the article “Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab” (Tweehuysen et al, Arthritis Rheumatol, Jan 2018) [link to full-text article]
We invite you to view the archived recording of the virtual review webinar which was held on May 14th and led by Dr. Vipul Jairath (CIBRN Chair) featuring the March 2018 article by Strik et al in The Lancet Gastroenterology & Hepatology: “Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial” [article abstract]